Information Provided By: 
Fly News Breaks for January 17, 2017
AMED
Jan 17, 2017 | 08:53 EDT
Craig-Hallum analyst Bill Bonello raised his price target for Amedisys to $60 from $48, saying he expects to see "significant" multiple expansion as investors factor in the "significantly improving growth outlook." The analyst says he would buy Amedisys' shares as the operating system transition is now complete, April quality scores should be "excellent," Medicare cuts will be less severe than initially expected for 2017, and Medicare reimbursement will move from headwind to tailwind in 2018. He reiterates a Buy rating on the shares.
News For AMED From the Last 2 Days
There are no results for your query AMED
